Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
6.95
-0.27 (-3.74%)
At close: Jan 23, 2026, 4:00 PM EST
6.85
-0.10 (-1.44%)
After-hours: Jan 23, 2026, 4:20 PM EST
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $482.11 million as of January 23, 2026. Its market cap has decreased by -53.88% in one year.
Market Cap
482.11M
Enterprise Value
-160.48M
1-Year Change
-53.88%
Ranking
Category
Stock Price
$6.95
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $482.11M, an increase of 127.03%. That is a compound annual growth rate of 13.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 482.11M | -1.84% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 504.99M |
| Monopar Therapeutics | 501.36M |
| Verastem | 492.42M |
| Aclaris Therapeutics | 487.55M |
| Niagen Bioscience | 481.34M |
| Contineum Therapeutics | 474.52M |
| Vanda Pharmaceuticals | 473.36M |
| Anavex Life Sciences | 469.97M |